An open randomized trial was conducted during two malaria transmission seasons ( 2011 and 2012 ) to assess the efficacy and safety of three combinations : dihydro-artemisinin-piperaquine ( DHAPQ ) , artemether-lumefantrine ( AL ) and artesunate-amodiaquine ( ASAQ ) .